Listing Page

Category: Regulatory Management

What You Need to Know About Post-Approval Change Pathways
Post-approval changes (PACs) – changes made to the drug substance manufacturing process after receiving...
Read More >
Preparing for DSCSA Track and Trace Implementation
Counterfeit drugs have become big business. In 2019, it was estimated that $200 billion worth of counterfeit...
Read More >
Why a CDMO Might Be the Best Place to Find Regulatory Support
The main goal for any drug company is achieving a speedy path to market. While many obstacles threaten...
Read More >
2 Key Factors to Accelerate Drug Approvals: Expertise and Relationships
Drug approvals are often complex and time-consuming, even for generic versions of approved medications....
Read More >
LGM Helps Pharma Manage Supply Chain Risks with Added Services Through Nexgen Acquisition
COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of...
Read More >